Xilio Therapeutics Balance Sheet (2024-2025) | XLO

Balance Sheet Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Assets
Current Assets
Cash & Equivalents 33.98M74.95M61.26M55.29M89.10M121.55M103.76M
Cash & Current Investments 33.98M74.95M61.26M55.29M89.10M121.55M103.76M
Receivables - Net 30.00M
Receivables 30.00M
Prepaid Assets 5.21M3.06M2.05M4.94M4.13M2.17M2.83M
Current Assets 69.19M78.01M63.31M60.23M93.20M123.72M124.09M
Non-Current Assets
Property, Plant & Equipment (Net) 5.54M5.14M4.84M4.47M4.29M4.02M3.68M
Other Non-Current Assets 2.76M1.77M1.77M1.78M1.79M1.79M1.80M
Non-Current Assets 13.42M11.87M11.35M10.84M10.52M10.10M9.61M
Assets 82.61M89.87M74.66M71.08M103.72M133.81M133.69M
Liabilities
Current Liabilities
Accounts Payables 0.75M1.26M0.97M2.57M2.27M4.10M2.30M
Payables 0.75M1.26M0.97M2.57M2.27M4.10M2.30M
Accumulated Expenses 8.00M9.74M9.79M9.98M3.88M5.62M8.95M
Other Accumulated Expenses 0.11M0.13M0.14M0.13M0.17M0.20M0.09M
Current Leases 1.08M1.12M1.15M1.19M1.23M1.26M1.30M
Current Deferred Revenue 21.73M26.52M26.11M32.78M78.99M70.91M69.34M
Total Current Liabilities 31.58M38.64M38.02M27.26M47.64M53.26M56.40M
Non-Current Liabilities
Non-Current Deffered Revenue 17.40M10.25M8.40M19.26M38.74M28.63M25.50M
Operating Leases 7.86M7.57M7.26M6.95M6.64M6.30M5.96M
Other Non-Current Liabilities 38.55M53.93M
Total Non-Current Liabilities 88.19M87.86M
Total Liabilities 56.84M56.46M53.68M53.48M93.02M126.74M141.79M
Shareholder's Equity
Common Equity 25.77M33.42M20.97M17.60M10.70M7.07M-8.10M
Shareholder's Equity 25.77M33.42M20.97M17.60M10.70M7.07M-8.10M
Liabilities and Shareholders Equity 82.61M89.87M74.66M71.08M103.72M133.81M133.69M
Retained Earnings -342.71M-356.64M-370.70M-383.75M-397.02M-412.90M-429.15M
Treasury Shares 0.48M0.45M0.45M0.45M0.33M0.33M0.33M